Erythropoietin in kidney disease and type 2 diabetes

N Engl J Med. 2011 Jan 27;364(4):384; author reply 385-6. doi: 10.1056/NEJMc1012157.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anemia / drug therapy*
  • Anemia / etiology
  • C-Reactive Protein / analysis
  • Darbepoetin alfa
  • Diabetes Mellitus, Type 2 / complications*
  • Erythropoietin / analogs & derivatives*
  • Erythropoietin / therapeutic use
  • Hematinics / therapeutic use*
  • Hemoglobins / analysis
  • Humans
  • Kidney Failure, Chronic / complications*
  • Risk

Substances

  • Hematinics
  • Hemoglobins
  • Erythropoietin
  • Darbepoetin alfa
  • C-Reactive Protein